202 related articles for article (PubMed ID: 11564124)
1. Safety profile of levetiracetam.
Harden C
Epilepsia; 2001; 42 Suppl 4():36-9. PubMed ID: 11564124
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
Chaisewikul R; Privitera MD; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
[TBL] [Abstract][Full Text] [Related]
4. Spotlight on levetiracetam in epilepsy.
Lyseng-Williamson KA
CNS Drugs; 2011 Oct; 25(10):901-5. PubMed ID: 21936590
[TBL] [Abstract][Full Text] [Related]
5. The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.
Morrell MJ; Leppik I; French J; Ferrendelli J; Han J; Magnus L
Epilepsy Res; 2003 May; 54(2-3):153-61. PubMed ID: 12837566
[TBL] [Abstract][Full Text] [Related]
6. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
7. An assessment of levetiracetam as an anti-epileptic drug.
Jain KK
Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
[TBL] [Abstract][Full Text] [Related]
8. Acute psychosis associated with levetiracetam.
Youroukos S; Lazopoulou D; Michelakou D; Karagianni J
Epileptic Disord; 2003 Jun; 5(2):117-9. PubMed ID: 12875956
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: the Asia SKATE II Study.
Kwan P; Lim SH; Chinvarun Y; Cabral-Lim L; Aziz ZA; Lo YK; Tonner F; Beh K; Edrich P;
Epilepsy Behav; 2010 May; 18(1-2):100-5. PubMed ID: 20462804
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial.
Glauser TA; Pellock JM; Bebin EM; Fountain NB; Ritter FJ; Jensen CM; Shields WD
Epilepsia; 2002 May; 43(5):518-24. PubMed ID: 12027913
[TBL] [Abstract][Full Text] [Related]
12. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial.
Ferrendelli JA; French J; Leppik I; Morrell MJ; Herbeuval A; Han J; Magnus L
Epilepsy Behav; 2003 Dec; 4(6):702-9. PubMed ID: 14698704
[TBL] [Abstract][Full Text] [Related]
13. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
Abou-Khalil B; Hemdal P; Privitera MD
Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam in refractory pediatric epilepsy.
Wheless JW; Ng YT
J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of levetiracetam.
Arroyo S; Crawford P
Epileptic Disord; 2003 May; 5 Suppl 1():S57-63. PubMed ID: 12915343
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
18. Catatonia induced by levetiracetam.
Chouinard MJ; Nguyen DK; Clément JF; Bruneau MA
Epilepsy Behav; 2006 Feb; 8(1):303-7. PubMed ID: 16249124
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of levetiracetam in clinical practice: results of the SKATE trial from Belgium and The Netherlands.
Lambrechts DA; Sadzot B; van Paesschen W; van Leusden JA; Carpay J; Bourgeois P; Urbain E; Boon PA
Seizure; 2006 Sep; 15(6):434-42. PubMed ID: 16893660
[TBL] [Abstract][Full Text] [Related]
20. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
